Blog Page 90

The Odd Couple – CombinatoRx brings matchmaking to drug discovery and development
While almost everyone in the drug industry is looking for ways to speed new drugs to market, CombinatoRx has taken a particularly pragmatic approach: Rather than looking for new drugs, it is searching for novel combinations of existing drugs with synergistic effects.

Biotechs big winners in VC rebound

Biotechnology companies are leading a rebound in venture capital investment in the New York metro area, a new survey shows.

Investors put $380 million into 56 companies in the second quarter of this year, for a 63% jump in venture capital investment over the first quarter, according to the MoneyTree Survey by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association.

Antibiotics, The Next Generation
Few things are as inexorable as the march of bacterial resistance. When a person or animal is given an antibiotic, it kills enough pathogens to cure the illness. But bacteria that have mutated so they can resist the drug survive. The next time these bacteria cause an infection, the antibiotic is less likely to work. But that is drawing some biotech companies into the antibiotic research.